Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results

Stock Information for Novo Integrated Sciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Novo Integrated Sciences Inc.

Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results
Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program
Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program
Novo Integrated Sciences' Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million
Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products
Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note
Novo Integrated Sciences' Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program
Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.